Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 25,000 Class A shares on 04/04/2024, with an aggregate market value of $225,500. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This upcoming sale follows a series of transactions over the past three months, where a total of 239,591 shares were sold for gross proceeds of approximately $2.4 million.